The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional ...

Gilead Sciences said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients ...

We recently compiled a list of 10 Most Promising Long-Term Stocks According to Hedge Funds. In this article, we will look at ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

Merck also changed the outlook for its Healthcare business to "slight growth", compared to a previously expected ...

In a report released yesterday, Chris Shibutani from Goldman Sachs maintained a Sell rating on Exelixis (EXEL – Research Report). The ...

Kulkarni's colorectal cancer was Stage 4. “That’s when the ground fell out from beneath me, basically. And I will never forget that feeling. But I will tell you that was the one day that I ...

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...